Zomedica Corp. (ZOM)
|Net Income (ttm)||-18.50M|
|Trading Day||May 13|
|Day's Range||0.690 - 0.810|
|52-Week Range||0.063 - 2.910|
ANN ARBOR, Mich, May 12, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats,...
Zomedica has potential in a niche business. But the price of ZOM stock does not yet reflect that.
If Truforma truly is a game-changer, there's hope the company could grab part of a potential $10.5 billion animal diagnostics market. The post Why Zomedica Stock Isn't Worth Buying Right Now appeared fi...
Stocks are always doing one of three things: Moving higher, moving lower or staying the same. When they're moving higher the bulls (buyers) control the market.
While ZOM stock has been highly volatile, the business is progressing. The Truforma platform has launched and we'll start seeing revenue figures soon.
Traders appear to be rotating out of these former highfliers.
We're diving back into the world of penny stocks again today as we look at those that are getting the most discussion over on Reddit. The post 5 Reddit Penny Stocks Seeing the Most Chatter Tuesday appea...
The music appears to be slowing for retail favorite ZOM stock, so the question is, will the volume get turned up, or will the music stop? The post As Zomedica Stock Loses Altitude, Is It Cheap Enough fo...
Zomedica may be worth a gamble at some point, but for now you can expect ZOM stock to continue falling well below $1 per share. The post Investor Impatience Will Send Zomedica Stock Back Below a Dollar ...
ZOM stock makes as much sense as it ever has right now. Truforma's best days are in front of it which is also true of Zomedica shares.
While cheap stocks have captured the imagination of speculators everywhere, you should avoid this space until it stabilizes. The post 7 Cheap Stocks to Avoid Until the Hype Retreats appeared first on In...
ZOM stock has pulled back sharply from its peak price, but Zomedica has an opportunity as it seeks to expand its market presence. The post Sales Model Shift Should Provide a Long-Term Boost for Zomedica...
ZOM stock is very attractive today, currently well below its target value of $1.63 and assuming it takes 10% of the pet diagnostic market. The post Zomedica Stock Is Very Attractive Here As Its New Prod...
ZOM stock double peaked last month before falling sharply, as investors await for Truforma's launch to pay off handsomely. The post Why Zomedica Stock is a Pure Gamble Right Now appeared first on Invest...
Reddit penny stocks are still all the rage from investors that aren't afraid of risks and we're taking a look at the most talked about today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Tuesd...
The bulls are on parade.
These biotech penny stocks have begun turning heads in April 2021 The post 3 Penny Stocks To Watch As Biotech Surges In April 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
Penny stocks are all the rage. Everyone's looking for the next GameStop.
Creating a penny stock watchlist? You should check these 3 out The post Best Penny Stocks to Buy?
Zomedica announced April 15 that it would move to direct sales. ZOM stock dropped on the news.
Biotech penny stocks continue to see momentum; should you add these 3 to your watchlist? The post Top Biotech Penny Stocks to Buy?
Reddit penny stocks continue to be a hot topic among investors looking to take out investments in companies without having to break the bank. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thurs...
Zomedica (ZOM) stock is taking off on Thursday despite a lack of news concerning the maker of medical devices for veterinarians. The post ZOM Stock: What Zomedica Investors Are Saying as the Pet Pharma ...
With tech penny stocks in focus, which companies should you watch? The post Tech Penny Stocks to Buy in 2021?
Despite releasing Truforma ahead of schedule, Zomedica still has to overcome tough challenges facing the product. Investors should not buy ZOM stock yet.
These ultra-popular Reddit stocks are fooling unsuspecting investors with their low share prices.
Initial sales of a key product may be lower than investors were hoping for.
After falling back to $1 per share, expect headline-making "meme stock" ZOM stock to give up even more of its recent gains. The post The Party's Over for Zomedica Stock, So Stay Away appeared first on I...
For those who have been waiting for a big discount in ZOM stock, it has arrived. Still, you may want to rethink this before committing.
ANN ARBOR, Mich., April 15, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs a...
The stock has been falling sharply in the past month.
Once flying high on their status as Reddit stocks, these nine penny stocks are falling back towards prior price levels. The post 9 Reddit Penny Stocks That Are Running Out of Gas appeared first on Inves...
The past year has been great for pet-related stocks, and ZOM stock is as much a perfect example as it is a cautionary tale. The post Zomedica Really Only Has Its Penny Status Keeping It Interesting appe...
Has ZOM stock bottomed or does it have further to fall? Investors who are interested in buying stock of animal health company Zomedica may want to pull the trigger with the share price down 47% since Ma...
With gains of 1,259% to 2,801%, these billion-dollar stocks have been unstoppable since early October.
Reddit penny stocks continue to be a hot subject among retail investors and we're looking at the most-talked-about ones today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared firs...
The retirement of preferred stock seems like a clear win for Zomedica and ZOM stock. But the deal raises a key question as well.
The early launch of Zomedica's Truforma does not guarantee commercial success. Before you bet on ZOM stock, the company needs to prove itself.
These high-flying stocks may soon reverse course.
ZOM stock is climbing higher today, reversing recent gains. However, a new Bloomberg report says it could be yesterday's news.
ZOM stock fell sharply after the March 16 launch of its veterinary platform. It needs solid sales before they will rise substantially again.
The interest in ZOM stock is purely speculative. There is absolutely zero reason to chase it stemming from the current fundamentals.
These brand-name and under-the-radar stocks delivered game-changing returns to start the year.
Sure, the jury's still out regarding how long "meme stock could continue. But, while it may be months until the bubble really bursts, it's still best to stay away from ZOM stock.
In the growing veterinary diagnostics market, Zomedia is making strides - yet, the market hasn't yet recognized the real value of ZOM stock. The post Pounce on This Pullback in the Zomedica Share Price ...
ZOM stock is popular right now. But betting on the future of its veterinary diagnostics product makes is too speculative of a play.
Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyro... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
According to one analyst, the rating for Zomedica stock is "Buy" and the 12-month stock price forecast is 1.20.